Clearmind Medicine to sell $1.5 million in convertible promissory notes at 90% of face value
Share
Listen to the news
Clearmind Medicine to sell $1.5 million in convertible promissory notes at 90% of face value
  • Clearmind Medicine entered a deal to sell $1.5 million of convertible promissory notes to CLA Investors, with closing expected on June 1, 2026.
  • Cash proceeds set at $1.35 million, reflecting a 90% purchase price to principal.
  • The issuance sits within an amended facility to issue up to $10 million of convertible promissory notes.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Clearmind Medicine Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-063494), on June 01, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending